Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jan. 01, 2023	Oct. 02, 2022
Par value of common stock	$ 0.001	$ 0.001
Authorized shares of common stock	2,400,000,000	2,400,000,000
Common Stock, Shares, Issued	1,148,500,000	1,147,900,000
Current assets:
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	$ 3,186.5	$ 2,818.4
Short-term investments	123.9	364.5
Accounts receivable, net	1,162.9	1,175.5
Inventories	2,088.1	2,176.6
Prepaid expenses and other current assets	373.5	483.7
Total current assets	6,934.9	7,018.7
Debt Securities, Available-for-Sale, Noncurrent	283.6	279.1
Equity investments	330.5	311.2
Property, plant and equipment, net	6,699.5	6,560.5
Operating lease, right-of-use asset	8,133.8	8,015.6
Deferred Income Tax Assets, Net	1,811.8	1,799.7
Other long-term assets	527.6	554.2
Other intangible assets	151.4	155.9
Goodwill	3,383.0	3,283.5
TOTAL ASSETS	28,256.1	27,978.4
Current liabilities:
Accounts payable	1,348.2	1,441.4
Accrued liabilities	2,089.6	2,137.1
Accrued payroll and benefits	664.6	761.7
Current portion of operating lease liability	1,257.5	1,245.7
Stored value card liability and current portion of deferred revenue	2,137.0	1,641.9
Short-term debt	0.0	175.0
Current portion of long-term debt	1,749.3	1,749.0
Total current liabilities	9,246.2	9,151.8
Long-term debt	13,176.7	13,119.9
Operating lease liability	7,635.4	7,515.2
Deferred revenue	6,263.2	6,279.7
Other long-term liabilities	600.5	610.5
Total liabilities	36,922.0	36,677.1
Shareholders' deficit:
Common stock ($0.001 par value) — authorized, 2,400.0 shares; issued and outstanding, 1,148.5 and 1,147.9 shares, respectively	1.1	1.1
Additional paid-in capital	67.2	205.3
Retained deficit	(8,203.2)	(8,449.8)
Accumulated other comprehensive income/(loss)	(538.9)	(463.2)
Total shareholders’ deficit	(8,673.8)	(8,706.6)
Noncontrolling interests	7.9	7.9
Total deficit	(8,665.9)	(8,698.7)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY/(DEFICIT)	$ 28,256.1	$ 27,978.4